Skip to main content
. Author manuscript; available in PMC: 2019 Jul 17.
Published in final edited form as: Int J Pharm. 2017 Mar 24;523(1):310–319. doi: 10.1016/j.ijpharm.2017.03.039

Table 2.

The uniformity and drug content of the loteprednol etabonate ointment formulations

Formulations Manufacturing Method Average Drug Loading ± SD(%, w/w) RSD (%)
SRTOWP19 Simple mixing for 6 minutes at 1,450 rpm at room temperature 0.48 ± 0.01 2.87
SRTNWP19 0.49 ± 0.01 1.60

HMICOWP19 Melting at 65°C for 30 min and stirring at 1,450 rpm for 5 mins followed by immediate cooling at −20°C for 2 h, −4°C for 15 h 0.49 ± 0.01 1.22
HMICNWP19 0.47 ± 0.00 0.91

HMRTOWP19 Melting at 65°C for 30 min and stirring at 1,450 rpm for 5 min followed by cooling at room temperature 0.51 ± 0.02 3.27
HMRTNWP19 0.48 ± 0.01 1.05